سعر امريوديفاسك 510مجم 15 قرص 5/10 مجم 2026

Fixed-dose oral tablet combining amlodipine (calcium channel blocker) and perindopril (ACE inhibitor), 5/10 mg as labelled (Amriodivasc, Amriya, Egypt); 15 tablets per pack.

• Treatment of high blood pressure (hypertension) and/or stable coronary artery disease, in patients already taking perindopril and amlodipine as separate tablets at the same dose levels.Population: AdultsMedicines Authority Malta

• Very common: oedema (fluid retention). Common: headache, dizziness, somnolence, vertigo, pins and needles, visual disturbances, tinnitus, palpitations, flushing, light-headedness due to low blood pressure, cough, shortness of breath, gastrointestinal disorders (nausea, vomiting, abdominal pain, taste disturbance, dyspepsia, diarrhoea, constipation), allergic reactions (rash, itching), muscle cramps, tiredness, weakness and ankle swelling.International label, equivalent formulation · Medicines Authority Malta

• Allergy to perindopril or any other ACE inhibitor, to amlodipine or any other calcium antagonist, or to any excipient; previous angioedema (with ACE inhibitor treatment, hereditary or of unknown cause).International label, equivalent formulation · Medicines Authority Malta
• Pregnancy beyond 3 months (also better avoided in early pregnancy).International label, equivalent formulation · Medicines Authority Malta
• Aliskiren-containing treatment in patients with diabetes or impaired kidney function; sacubitril/valsartan; dialysis or other extracorporeal blood treatments that may increase the risk of allergic reactions; significant renal artery stenosis.International label, equivalent formulation · Medicines Authority Malta

• Angioedema (swelling of face, lips, tongue or throat with difficulty swallowing or breathing) may occur at any time with ACE inhibitors; stop the medicine and seek medical help immediately. Risk is higher with racecadotril, mTOR inhibitors (sirolimus, everolimus, temsirolimus), sacubitril and gliptins, and in black patients.International label, equivalent formulation · Medicines Authority Malta
• Use with caution (tell the doctor) in hypertrophic cardiomyopathy, renal artery stenosis, heart failure, hypertensive crisis, liver or kidney disease or dialysis, primary aldosteronism, collagen vascular disease (e.g. SLE, scleroderma), diabetes, salt-restricted diet or potassium-containing salt substitutes, and in elderly patients needing dose increases.International label, equivalent formulation · Medicines Authority Malta
• Dual RAS blockade with an ARB or aliskiren requires monitoring of kidney function, blood pressure and electrolytes (e.g. potassium).International label, equivalent formulation · Medicines Authority Malta

• LithiumAvoid combination (risk of increased lithium levels).Medicines Authority Malta
• EstramustineAvoid combination.Medicines Authority Malta
• Potassium-sparing diuretics, potassium supplements, potassium-containing salt substitutes, heparin, trimethoprim/co-trimoxazole, eplerenone/spironolactoneAvoid combination or monitor: may increase blood potassium.Medicines Authority Malta

• Not recommended in early pregnancy and must not be taken after the third month, as it may cause serious harm to the baby; the doctor will normally advise stopping before pregnancy or as soon as pregnancy is known.International label, equivalent formulation · Medicines Authority Malta
• Not recommended during breastfeeding; amlodipine has been shown to pass into breast milk in small amounts.International label, equivalent formulation · Medicines Authority Malta

English text not available for this section.